Authors : Bhanu Prakash Manjappasetty Masagali

Volume/Issue : Volume 10 - 2025, Issue 1 - January

Google Scholar : https://tinyurl.com/3nwf6kxy

Scribd : https://tinyurl.com/yc4ampub

DOI : https://doi.org/10.5281/zenodo.14737726

Abstract : As the global population ages, the prevalence of cognitive decline and dementia, including Alzheimer's disease, continues to rise, impacting millions of individuals and placing a significant burden on healthcare systems. Early prediction and accurate monitoring of dementia progression are critical for timely intervention, personalized care, and slowing disease advancement. However, traditional diagnostic approaches face challenges, such as reliance on late-stage biomarkers, limited sensitivity of cognitive assessments, and inconsistencies in neuroimaging. This review explores how artificial intelligence (AI) and machine learning (ML) are transforming the field of dementia prediction, offering a paradigm shift toward earlier and more accurate assessments. This paper systematically examines recent advancements in AI and ML applications in predicting cognitive decline and tracking dementia progression. Key technologies discussed include deep learning for neuroimaging analysis, natural language processing (NLP) for speech and language pattern identification, and time-series analysis for continuous monitoring through wearable devices. The role of multimodal data integration, encompassing genetic, behavioral, clinical, and imaging data, is highlighted as a critical advancement that AI can facilitate, allowing for a comprehensive and personalized approach to risk prediction. Despite AI's potential, significant challenges remain, including data quality and diversity, ethical concerns in predictive diagnostics, and the "black-box" nature of many AI models that make clinical interpretability difficult. The review also discusses the regulatory and ethical landscape, underscoring the need for transparent, unbiased, and privacy-conscious AI applications in healthcare. Future directions are proposed, such as advancements in explainable AI (XAI), integration of precision medicine approaches, and the role of AI in supporting drug development and clinical trials. In conclusion, while AI and ML offer promising tools for enhancing dementia prediction and management, a collaborative approach involving researchers, clinicians, policymakers, and patients is essential to harness AI's potential responsibly and equitably. This paper calls for continued research, interdisciplinary partnerships, and regulatory guidance to ensure AI's ethical and effective integration into dementia care and management. Keywords: Artificial Intelligence (AI),Machine Learning (ML), Dementia Prediction, Cognitive Decline, Alzheimer’s Disease, Early Diagnosis, Predictive Modeling, Neuroimaging, Genetic Biomarkers, Multi-modal Data Integration, Wearable Devices, Digital Biomarkers, Explainable AI (XAI), Federated Learning, Synthetic Data, Data Privacy in Healthcare, AI in Healthcare, Clinical Decision Support Systems (CDSS), Real-time Monitoring, Personalized Care, Neurodegenerative Diseases, Patient-Centered Care, AI Ethics, Bias in AI, Privacy-Preserving AI, Longitudinal Data Analysis, Cognitive Assessment, Patient Outcomes, Regulatory Standards for AI, AI in Dementia Care, Proactive Healthcare, Dementia Progression Monitoring, AI-Driven Healthcare Innovations, Clinical Applications of AI, Ethical AI in Healthcare.

References :

1. Oskarsson, M. E., & Xie, L. (2020). Machine learning in Alzheimer’s disease: A literature review. Journal of Alzheimer’s Disease, 77(1), 1-16.
2. Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44-56.
3. Zhang, C., & Wang, F. (2021). Artificial intelligence for early diagnosis and prognosis of Alzheimer's disease: A comprehensive review. Frontiers in Aging Neuroscience, 13, 667624.
4. Davis, M. E., & Li, X. (2020). Artificial intelligence in dementia diagnosis: Clinical and ethical considerations. Journal of Clinical Neurology, 16(2), 157-162.
5. Glenner, G. G., & Wong, C. W. (2020). Alzheimer's disease: Neuroimaging, genetics, and machine learning. Journal of Neural Engineering, 17(1), 066016.
6. Jin, L., & Wang, X. (2022). Deep learning in neuroimaging and dementia prediction: Techniques, challenges, and opportunities. Frontiers in Neuroscience, 16, 784171.
7. Koutsouleris, N., & Meisenzahl, E. M. (2021). Machine learning for early detection of neurodegenerative diseases: Applications in Alzheimer’s and beyond. The Lancet Neurology, 20(9), 775-786.
8. Ng, S. S., & Lam, W. K. (2021). AI in healthcare: Ethical implications and challenges in the context of dementia care. Frontiers in Artificial Intelligence, 4, 609659.
9. Blanke, O., & O'Reilly, J. (2022). Federated learning for privacy-preserving healthcare AI. IEEE Transactions on Artificial Intelligence, 3(3), 204-215.
10. Mast, J., & Shimizu, A. (2020). Explainable AI in clinical dementia research. Nature Medicine, 26(2), 213-222.
11. Wang, Z., & Li, J. (2023). Advancements in AI for dementia prediction: Integration of multi-modal data. Alzheimer's & Dementia, 19(7), 1153-1165.
12. Rohani, D., & Khosla, R. (2022). Challenges and opportunities in the application of AI in healthcare. Healthcare Technology Letters, 9(4), 157-168.
13. Reis, L. A., & Santos, C. F. (2023). Digital biomarkers and AI in Alzheimer's disease. Computational Biology and Chemistry, 95, 107488.
14. Jones, C. A., & Williams, L. A. (2023). Machine learning models for dementia prediction: A review of validation studies. Journal of Neural Engineering, 17(2), 2036-2045.